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Kaposi’s sarcoma associated herpesvirus (KSHV) in the
etiological agent for 3 AIDS-related cancers: Kaposi’s sar-
coma (KS), primary effusion lymphoma, and multicentric
Castleman’s disease. The molecular mechanisms used by
KSHV to induce cancer are incompletely understood. KS
lesions harbor proliferating latently-infected endothelial
cells (ECs), large numbers of inflammatory cells, and
marked neoangiogenesis. Considered the major driving
force in the development of KS, these KSHV-infected
ECs elaborate a variety of pro-inflammatory and angio-
genic factors that contribute to tumourigenesis. Consid-
erable evidence has accumulated suggesting a critical role
for activated signal transducer and activator of transcrip-
tion-3 (STAT3) in malignant transformation. STAT3 is a
latent transcription factor that upon activation, drives the
expression of a number of genes involved in cell prolif-
eration, survival, and immune responses. Canonical
STAT3 activation occurs via phosphorylation of Y705,
dimerization, and nuclear translocation, followed by
phosphorylation of S727 for maximal transcriptional
activity. Activated STAT3 has been observed in a variety
of malignancies and has been shown to induce fibroblast
transformation in vitro suggesting that STAT3 is a proto-
oncogene. Interestingly, evidence has accumulated sug-
gesting a role for S727 mono-phosphorylated STAT3.
Here we show that latent KSHV infection of primary
human endothelial cells (ECs) in vitro activates STAT3,
and identify a key latency protein, kaposin B, that contri-
butes to this activation. Kaposin B expression in ECs
causes STAT3 phosphorylation at S727, in the absence of
significant Y705 phosphorylation, and enhanced expres-
sion of a subset of STAT3 target genes including CCL5.
Recent work shows that the tripartite motif-containing
protein 28 (TRIM28, a.k.a. TIF-1b, KAP-1) negatively
regulates STAT3 by recruiting transcriptional silencing
complexes. The repressive activity of TRIM28 is
mediated by post-translational modifications and a key
site in the regulation of repressor activity maps to S473.
Phosphorylation of this residue disrupts the recruitment
of transcriptional silencing complexes effectively deacti-
vating the co-repressive function of TRIM28. Confocal
microscopy and western blot analysis demonstrate phos-
phorylation of TRIM28 at S473 in KSHV latently infected
and kaposin B expressing ECs. Taken together, our stu-
dies suggest kaposin B may contribute to tumourigenesis
via constitutive activation of STAT3.
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